*001642589
*00520230228155608.0
*007ta
*008130222s2001    no            000 0 nob
*00901963cam a2200469 c 4500
*015  $a0605958$2nbf
*019  $bl
*020  $a8291049335$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)990122763914702201
*035  $a(NO-LaBS)13874052(bibid)
*035  $a(NO-TrBIB)012276391
*035  $a012276391-47bibsys_network
*040  $aNO-OsNB$bnob$ekatreg
*042  $anorbibl
*044  $cno
*060 4$aQV 77.9
*060 4$aQV 92
*060 4$aWM 270
*08274$a615.78$qNO-OsNB$24/nor
*1001 $aBachs, Liliana C.$d1962-$0(NO-TrBIB)1100887$_66662700
*24510$aBuprenorfin i legemiddelassistert rehabilitering :$bhva vet vi i dag?$cLiliana C. Bachs, Jørgen Bramness, Helge Waal
*260  $aOslo$bStatens rettstoksikologiske institutt$c2001
*300  $a[42] s.
*533  $aElektronisk reproduksjon$b[Norge]$cNasjonalbiblioteket Digital$d2016-07-07
*650 2$aBuprenorphine$_65084800
*650 2$aBuprenorphine$xtherapeutic use$_93153300
*650 2$aNorway$_10050600
*650 2$aRehabilitation$_10640100
*650 2$aSubstance-Related Disorders$_10483700
*650 2$aSubstance-Related Disorders$xrehabilitation$_14240300
*651 4$aNorway$_10050600
*653  $alegemiddel$aassistert$abehandling$arus$arehabilitering$aopioider$atemgesic$arusmidler$atoksikologi$asubutex$anarkotika$asubstanceabuse$atoxicology$adrugs$anarcotics$aburprenorfin$_93153400
*7001 $aBramness, Jørgen G.$d1962-$0(NO-TrBIB)97009990$_42938300
*7001 $aWaal, Helge$d1940-$0(NO-TrBIB)90063524$_13810400
*7102 $aRegionalt legemiddelinformasjonssenter$bHelseregion øst$0(NO-TrBIB)1100884$_93153500
*7102 $aStatens rettstoksikologiske institutt$0(NO-TrBIB)1100886$_93153600
*7102 $aUniversitetet i Oslo$bSeksjon for kliniske rusmiddelproblemer$0(NO-TrBIB)1100885$_57570100
*7760 $tBuprenorfin i legemiddelassistert rehabilitering : hva vet vi i dag?$w990937132824702201
*85641$3Fulltekst$uhttps://urn.nb.no/URN:NBN:no-nb_digibok_2016070708241$yNettbiblioteket$zDigital representasjon
*901  $a90
*913  $aNorbok$bNB
*999  $aoai:nb.bibsys.no:990122763914702202$b2021-11-14T20:38:14Z$z990122763914702202
^